A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Peter Jung(Boehringer Ingelheim (Germany)), Juan Manuel García‐Martínez(Boehringer Ingelheim (Germany))
Cited by 1
Related Papers
Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice
|British Journal of Cancer|2011|48
Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer
|Cellular and Molecular Gastroenterology and Hepatology|2021|30